에서 실시간으로 운영 중이에요! 자세히 알아보기

InfuSystem Holdings

INFU

시가총액 US$2.67억

13.40 USD

-0.52

3.74%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

프리마켓

시간외 거래

13.40

0.00

0%

1일

-3.74%

5일

-1.47%

1개월

7.63%

3개월

45.02%

6개월

30.99%

연초 이후

59.71%

1년

44.24%

5년

2.29%

10년

425.49%

소개: InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.

직원 수: 473

건강관리 의료 장비 및 용품

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 22.2%

중립 77.8%

부정적 0%

InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript

InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript

InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript

InfuSystem to Host Investor Webcast on September 24, 2026

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Host Investor Webcast on September 24, 2026.

InfuSystem to Host Investor Webcast on September 24, 2026

InfuSystems: More Upside Ahead

InfuSystems has shifted to a profit-focused strategy, driving a 24% FY25 adjusted EBITDA increase and maintaining strong margins despite GE contract restructuring. Wound Care revenue surged 154% due to partnerships and favorable reimbursement, while Oncology achieved record volumes and robust Patient Services growth. INFU's balance sheet remains conservative, with net debt at 0.61x EBITDA, $55.2M liquidity, and ongoing share repurchases reducing share count by 5% in H1.

InfuSystems: More Upside Ahead

The London Company Large Cap Vs. Russell 1000 Q2 2026 Portfolio Review

The London Company Large Cap portfolio returned 10.9% (10.7% net) during the quarter vs. a 15.1% increase in the Russell 1000 Index. ENTG was a top contributor, benefiting from improving fab utilization and accelerating AI-driven semiconductor demand. RSG declined despite another solid quarter as softer Environmental Solutions results and continued weakness in construction-related volumes weighed on investor sentiment.

The London Company Large Cap Vs. Russell 1000 Q2 2026 Portfolio Review

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

Astrana Health outperformed as the company results have continued to demonstrate that it was not taking advantage of loopholes within Medicare coding. Magnolia Oil & Gas saw shares decline after an agreement was reached to end the war between the US and Iran and reopen the Strait of Hormuz. We initiated a position in Insteel Industries, the nation's largest manufacturer of steel wire reinforcing products for concrete construction.

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript

Zacks Investment Research

InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates

InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.12 per share a year ago.

InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates

InfuSystem Announces Financial Results for Second Quarter 2026

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Second Quarter 2026.

InfuSystem Announces Financial Results for Second Quarter 2026

InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026.

InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026

Zacks Investment Research

Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.